U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Bivalirudin Injection
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Pfizer Inc. (New 07/24/2023)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
Bivalirudin, Injection, 250 mg (NDC 0409-8300-15) 07/24/2023 Supply expected to exhaust late September 2023; Discontinuation of the manufacture of the drug
Back to Top